Business
Press Release Jul 13 2023
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated July 13, 2023, titled "FDA issues complete response letter for PDP-716 NDA due to inspection findings at third-party API manufacturing facility".
About this update from Sun Pharma Advanced Research Co. Ltd.
[{"type":"text","content":" Sun Pharma Advanced Research Company Limited has informed the Exchange regarding a press release dated July 13, 2023, titled \"FDA issues complete response letter for PDP-716 NDA due to inspection findings at third-party API manufacturing facility\". View Attachment","length":405,"tagName":"div"}]